Thomas Klenner
11Patents
6h-index
30Co-inventors
58Inventor score
Filing activity: Nov 1, 1994 → Oct 17, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6693119B2 | Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties | Human Necessities | 10 | Expired |
| US6403636B1 | Xanthone compounds, their preparation and use as medicament | Human Necessities | 9 | Expired |
| US5942493A | LH-RH antagonists having improved action | Chemistry; Metallurgy | 8 | Expired |
| US5622685A | Polyether-substituted porphyrin anti-tumor agents | Human Necessities | 8 | Expired |
| US6093704A | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 7 | Expired |
| US6696428B2 | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 6 | Expired |
| US6544551B1 | Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7452910B2 | Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties | Human Necessities | 3 | Expired |
| US5556836A | Use of D-glucopyranuronic acids and their derivatives for incorporation in pharmacologically active peptides and their salts | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5837462A | Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs | Chemistry; Metallurgy | 1 | Expired |
| US6576624B1 | Use of dopamine receptor antagonists in palliative tumor therapy | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.